Healthcare Digital Twins Market Size, Share & Trends Analysis Report By Type (Process & System Digital Twin, Product Digital Twin), By Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030

Healthcare Digital Twins Market Size, Share & Trends Analysis Report By Type (Process & System Digital Twin, Product Digital Twin), By Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030

Healthcare Digital Twins Market Growth & Trends

The global healthcare digital twins market size is expected to reach USD 3.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 25.6% from 2022 to 2030. Digital twins are digital models or real-time replicas of an object or process that incorporates and updates all the available data in real time.

The technology is used in healthcare to test the safety and economic viability of a scenario before it is launched into the real world. The adoption of digital twins in the healthcare industry is still in a nascent stage but scientists are adopting the technology to test viability of surgical procedures and develop personalized medicine. These are some of the key factors anticipated to fuel the market growth during the forecast period. For instance, digital twins are used in healthcare to study diseases such as multiple sclerosis and Alzheimer’s to better understand the treatment options and accelerate clinical trial timelines.

Rising adoption of artificial intelligence in healthcare is anticipated to further drive the adoption of the technology. Integration of components such as APIs, graph databases, and natural language processing (NLP) to craft digital twins for healthcare and other life science organizations helps to reduce medical costs and enhance medical outcomes. Digital twins help to transform the industry by offering data backed feedback, data capturing, and data interventions, which are anticipated to considerably reduce the healthcare costs.

Emergence of startups and entry of key players in the market are anticipated to significantly boost the growth of the market. For instance, Sim&Cure, a France-based company, provides Sim&Size, a digital twin solution that helps brain surgeons to treat an aneurysm using simulations. Aneurysms are enlarged vessels that can cause stroke and clots in the brain. Moreover, increased funding provided to the startups is anticipated to promote the adoption of the technology during the forecast period. For instance, in October 2021, Twin Health, a California and Chennai-based startup, raised USD 140 million in a Series C funding round. The startup is an AI-powered platform that provides doctors and patients the guidance on sleep activity, nutrition, and meditative breathing that helps to reverse and prevent chronic conditions such as liver diseases, Type-II diabetes, and cardiovascular diseases.

In addition, various government initiatives to improve the adoption of digital twins are anticipated to drive the demand for the technology. For instance, DigiTwins, a flagship project launched by European Government aims to bring paradigm shifts in the healthcare industry using communication, advanced omics, sensing technologies, and computing. The European government plans to invest USD 1.1 billion in the project over 10 years to support the growth and development.

Healthcare Digital Twins Market Report Highlights

  • In 2021, the process and system digital twin segment held the largest share of over 65.0% due to the ability of the technology to provide better outcomes
  • In 2021, the asset and process management segment dominated the market with a share of over 35.0% owing to the rising adoption by healthcare facilities in order to manage their assets efficiently
  • In 2021, hospitals and clinics dominated the market with a share of over 30.0% due to the use of digital twins to optimize hospital working and increase efficiency of the facility
  • In 2021, North America held the largest share of over 45.0%. Factors such as favorable government initiatives, lucrative funding, and presence of key players in the region contributed to the growth of the market
Please note The report will be delivered in 4-8 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definition
1.3. Research Methodology
1.3.1. Information Procurement
1.3.1.1. Purchased database
1.3.1.2. GVR’s internal database
1.3.2. Primary Research
1.4. Research Scope and Assumptions
1.5. List to Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.4. Remote Patient Monitoring Software and Services Market
Chapter 3. Remote Patient Monitoring Software and Services Market Variables, Trends, & Scope
3.1. Penetration and Growth Prospect Mapping
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.3. Remote Patient Monitoring Software and Services Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.3. Major Deals & Strategic Alliances Analysis
3.3.4. Impact of COVID-19 on the market
Chapter 4. Chapter 5 Remote Patient Monitoring Software and Services Market: Type Estimates & Trend Analysis
4.1. Definitions & Scope
4.2. Remote Patient Monitoring Software and Services Market: Type Movement Analysis, USD Million, 2021 & 2030
4.3. Software
4.3.1. Software market estimates and forecasts, 2016 - 2030 (USD Million)
4.4. Services
4.4.1. Services market estimates and forecasts, 2016 - 2030 (USD Million)
Chapter 5. Remote Patient Monitoring Software and Services Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.2. Remote Patient Monitoring Software and Services Market: Application Movement Analysis, USD Million, 2021 & 2030
5.3. Cancer
5.3.1. Cancer market estimates and forecasts, 2016 - 2030 (USD Million)
5.4. Cardiovascular Diseases
5.4.1. Cardiovascular Diseases market estimates and forecasts, 2016 - 2030 (USD Million)
5.5. Diabetes
5.5.1. Diabetes market estimates and forecasts, 2016 - 2030 (USD Million)
5.6. Sleep Disorder
5.6.1. Sleep Disorder market estimates and forecasts, 2016 - 2030 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecasts, 2016 - 2030 (USD Million)
Chapter 6. Remote Patient Monitoring Software and Services Market: End-user Estimates & Trend Analysis
6.1. Definitions and Scope
6.2. Remote Patient Monitoring Software and Services Market: End User Movement Analysis, USD Million, 2021 & 2030
6.3. Payers
6.3.1. Payers market estimates and forecasts, 2016 - 2030 (USD Million)
6.4. Patients
6.4.1. Patients market estimates and forecasts, 2016 - 2030 (USD Million)
6.5. Providers
6.5.1. Providers market estimates and forecasts, 2016 - 2030 (USD Million)
Chapter 7. Remote Patient Monitoring Software and Services Market: Regional Estimates & Trend Analysis
7.1. Regional Market Snapshot
7.2. Remote Patient Monitoring Software and Services Market: Regional Movement Analysis
7.3. North America
7.3.1. North America market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.3.2. North America market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.3.3. North America market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.3.4. U.S.
7.3.4.1. U.S. market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.3.4.2. U.S. market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.3.4.3. U.S. market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.3.5. Canada
7.3.5.1. Canada market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.3.5.2. Canada market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.3.5.3. Canada market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.4. Europe
7.4.1. Europe market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.4.2. Europe market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.4.3. Europe market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.4.4. Germany
7.4.4.1. Germany market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.4.4.2. Germany market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.4.4.3. Germany market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.4.5. U.K.
7.4.5.1. U.K. market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.4.5.2. U.K. market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.4.5.3. U.K. market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.4.6. France
7.4.6.1. France market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.4.6.2. France market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.4.6.3. France market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.4.7. Italy
7.4.7.1. Italy market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.4.7.2. Italy market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.4.7.3. Italy market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.4.8. Spain
7.4.8.1. Spain market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.4.8.2. Spain market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.4.8.3. Spain market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.4.9. Russia
7.4.9.1. Russia market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.4.9.2. Russia market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.4.9.3. Russia market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.5.2. Asia Pacific market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.5.3. Asia Pacific market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.5.4. Japan
7.5.4.1. Japan market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.5.4.2. Japan market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.5.4.3. Japan market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.5.5. China
7.5.5.1. China market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.5.5.2. China market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.5.5.3. China market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.5.6. India
7.5.6.1. India market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.5.6.2. India market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.5.6.3. India market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.5.7. Australia
7.5.7.1. Australia market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.5.7.2. Australia market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.5.7.3. Australia market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.5.8. South Korea
7.5.8.1. South Korea market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.5.8.2. South Korea market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.5.8.3. South Korea market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.5.9. Singapore
7.5.9.1. Singapore market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.5.9.2. Singapore market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.5.9.3. Singapore market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.6. Latin America
7.6.1. Latin America market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.6.2. Latin America market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.6.3. Latin America market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.6.4. Brazil
7.6.4.1. Brazil market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.6.4.2. Brazil market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.6.4.3. Brazil market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.6.5. Mexico
7.6.5.1. Mexico market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.6.5.2. Mexico market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.6.5.3. Mexico market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.6.6. Argentina
7.6.6.1. Argentina market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.6.6.2. Argentina market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.6.6.3. Argentina market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.7. MEA
7.7.1. MEA market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.7.2. MEA market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.7.3. MEA market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.7.4. South Africa
7.7.4.1. South Africa market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.7.4.2. South Africa market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.7.4.3. South Africa market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.7.5. Saudi Arabia
7.7.5.1. Saudi Arabia market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.7.5.2. Saudi Arabia market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.7.5.3. Saudi Arabia market estimates and forecasts, by End User 2016 - 2030 (USD Million)
7.7.6. UAE
7.7.6.1. UAE market estimates and forecasts, by type 2016 - 2030 (USD Million)
7.7.6.2. UAE market estimates and forecasts, by application 2016 - 2030 (USD Million)
7.7.6.3. UAE market estimates and forecasts, by End User 2016 - 2030 (USD Million)
Chapter 8. Remote Patient Monitoring Software and Services Market - Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Competition Categorization
8.3. Vendor Landscape
8.3.1. Public Companies
8.3.2. Private Companies
Chapter 9. Company Profiles
9.1. Teladoc Health, Inc
9.1.1. Company overview
9.1.2. Financial performance
9.1.3. Product benchmarking
9.1.4. Strategic initiatives
9.2. Medtronic Plc.
9.2.1. Company overview
9.2.2. Financial performance
9.2.3. Product benchmarking
9.2.4. Strategic initiatives
9.3. GE Healthcare
9.3.1. Company overview
9.3.2. Financial performance
9.3.3. Product benchmarking
9.3.4. Strategic initiatives
9.4. Siemens Healthineers AG
9.4.1. Company overview
9.4.2. Financial performance
9.4.3. Product benchmarking
9.4.4. Strategic initiatives
9.5. Philips Healthcare
9.5.1. Company overview
9.5.2. Financial performance
9.5.3. Product benchmarking
9.5.4. Strategic initiatives
9.6. Caretaker Medical
9.6.1. Company overview
9.6.2. Financial performance
9.6.3. Product benchmarking
9.6.4. Strategic initiatives
9.7. OMRON Healthcare
9.7.1. Company overview
9.7.2. Financial performance
9.7.3. Product benchmarking
9.7.4. Strategic initiatives
9.8. BioIntelliSense
9.8.1. Company overview
9.8.2. Financial performance
9.8.3. Product benchmarking
9.8.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings